These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 24094552)
41. The rehabilitation programme of an adult phenylketonuria with upper motor neuron involvement. Soyupek F; Koyuncuoglu H; Cindas A; Ilgun E; Tak R J Back Musculoskelet Rehabil; 2009; 22(1):49-53. PubMed ID: 20023364 [TBL] [Abstract][Full Text] [Related]
42. The outcome of white matter abnormalities in early treated phenylketonuric patients: A retrospective longitudinal long-term study. Mastrangelo M; Chiarotti F; Berillo L; Caputi C; Carducci C; Di Biasi C; Manti F; Nardecchia F; Leuzzi V Mol Genet Metab; 2015 Nov; 116(3):171-7. PubMed ID: 26283467 [TBL] [Abstract][Full Text] [Related]
43. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545 [TBL] [Abstract][Full Text] [Related]
44. Serum ischemia modified albumin is a possible new marker of oxidative stress in phenylketonuria. Keshavarzi F; Rastegar M; Vessal M; Rafiei Dehbidi G; Khorsand M; Ganjkarimi AH; Takhshid MA Metab Brain Dis; 2018 Jun; 33(3):675-680. PubMed ID: 29270710 [TBL] [Abstract][Full Text] [Related]
45. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study. Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792 [TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance imaging of the brain in adolescents with phenylketonuria and in one case of 6-pyruvoyl tetrahydropteridine synthase deficiency. Pietz J; Meyding-Lamadé UK; Schmidt H Eur J Pediatr; 1996 Jul; 155 Suppl 1():S69-73. PubMed ID: 8828614 [TBL] [Abstract][Full Text] [Related]
47. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria. Gropper SS; Yannicelli S; White BD; Medeiros DM Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326 [TBL] [Abstract][Full Text] [Related]
48. Plasma thiols and their determinants in phenylketonuria. Colomé C; Artuch R; Sierra C; Brandi N; Lambruschini N; Campistol J; Vilaseca MA Eur J Clin Nutr; 2003 Aug; 57(8):964-8. PubMed ID: 12879091 [TBL] [Abstract][Full Text] [Related]
49. Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C. Martinez-Cruz F; Pozo D; Osuna C; Espinar A; Marchante C; Guerrero JM J Neurosci Res; 2002 Aug; 69(4):550-8. PubMed ID: 12210848 [TBL] [Abstract][Full Text] [Related]
50. Brain phenylalanine concentration in the management of adults with phenylketonuria. Moats RA; Koch R; Moseley K; Guldberg P; Guttler F; Boles RG; Nelson MD J Inherit Metab Dis; 2000 Feb; 23(1):7-14. PubMed ID: 10682303 [TBL] [Abstract][Full Text] [Related]
51. Comparison of atherogenic risk factors among poorly controlled and well-controlled adolescent phenylketonuria patients. Gündüz M; Çakar S; Kuyum P; Makay B; Arslan N Cardiol Young; 2016 Jun; 26(5):901-8. PubMed ID: 26278115 [TBL] [Abstract][Full Text] [Related]
52. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304 [TBL] [Abstract][Full Text] [Related]
53. Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria. Andrade F; Villate O; Couce ML; Bueno MA; Alcalde C; de Las Heras J; Ceberio L; Núñez-Marcos S; Nambo PS; Aldámiz-Echevarría L Eur J Pediatr; 2019 Jun; 178(6):903-911. PubMed ID: 30941500 [TBL] [Abstract][Full Text] [Related]
54. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels. Martynyuk AE; Ucar DA; Yang DD; Norman WM; Carney PR; Dennis DM; Laipis PJ Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755 [TBL] [Abstract][Full Text] [Related]
55. Urinary biomarkers of oxidative stress and plasmatic inflammatory profile in phenylketonuric treated patients. Deon M; Sitta A; Faverzani JL; Guerreiro GB; Donida B; Marchetti DP; Mescka CP; Ribas GS; Coitinho AS; Wajner M; Vargas CR Int J Dev Neurosci; 2015 Dec; 47(Pt B):259-65. PubMed ID: 26456498 [TBL] [Abstract][Full Text] [Related]
56. Parenteral nutrition in a premature infant with phenylketonuria. Cole DE; Landry DA JPEN J Parenter Enteral Nutr; 1984; 8(1):42-4. PubMed ID: 6422071 [TBL] [Abstract][Full Text] [Related]
57. Serum tyrosine within the first hour after an oral load of phenylalanine. Güttler F; Hansen G Scand J Clin Lab Invest; 1977 Dec; 37(8):717-21. PubMed ID: 601515 [TBL] [Abstract][Full Text] [Related]
58. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065 [TBL] [Abstract][Full Text] [Related]
59. Neurological manifestations in adults with phenylketonuria: new cases and review of the literature. Jaulent P; Charriere S; Feillet F; Douillard C; Fouilhoux A; Thobois S J Neurol; 2020 Feb; 267(2):531-542. PubMed ID: 31701331 [TBL] [Abstract][Full Text] [Related]
60. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets. Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]